What is the current stock price of LadRx Corporation (LADX)?

As of the latest market data, LadRx Corporation (LADX) is trading at $0.05. The stock has seen a loss of -50.00% today.

Does LadRx Corporation (LADX) pay a dividend?

Based on current data, LadRx Corporation does not have a confirmed active dividend policy.

What is the market cap of LadRx Corporation?

The current market capitalization of LadRx Corporation (LADX) is approximately unavailable.

LADX

LadRx Corporation·Healthcare

0.05

50.000%(−0.05)

Close Price

0.10

100.000%(+0.05)

Pre-Market

Last Updated: — ET

52W L: $0.0152W H: $2.40

Company Profile

LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

1989-03-29

Beta

1.56

Websitewww.cytrx.com↗